Rothschild Investment Corp IL raised its holdings in CVS Health Corp (NYSE:CVS) by 2.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 146,192 shares of the pharmacy operator’s stock after purchasing an additional 3,077 shares during the quarter. CVS Health comprises approximately 1.4% of Rothschild Investment Corp IL’s portfolio, making the stock its 15th largest holding. Rothschild Investment Corp IL’s holdings in CVS Health were worth $11,508,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of CVS. Camarda Financial Advisors LLC acquired a new position in shares of CVS Health during the second quarter worth about $102,000. Canton Hathaway LLC acquired a new position in shares of CVS Health during the third quarter worth about $126,000. Kiley Juergens Wealth Management LLC acquired a new position in shares of CVS Health during the second quarter worth about $103,000. Legacy Advisors LLC increased its stake in shares of CVS Health by 7,100.0% during the second quarter. Legacy Advisors LLC now owns 1,800 shares of the pharmacy operator’s stock worth $116,000 after acquiring an additional 1,775 shares during the period. Finally, Squar Milner Financial Services LLC acquired a new position in shares of CVS Health during the second quarter worth about $122,000. Institutional investors own 82.88% of the company’s stock.
In related news, EVP Lisa Bisaccia sold 21,534 shares of the business’s stock in a transaction dated Monday, October 1st. The shares were sold at an average price of $80.00, for a total transaction of $1,722,720.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Eva C. Boratto sold 13,311 shares of the business’s stock in a transaction dated Monday, September 17th. The stock was sold at an average price of $77.16, for a total transaction of $1,027,076.76. Following the sale, the executive vice president now directly owns 55,162 shares in the company, valued at approximately $4,256,299.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 43,409 shares of company stock worth $3,392,097. 0.53% of the stock is owned by insiders.
A number of brokerages have recently issued reports on CVS. ValuEngine upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, October 11th. Royal Bank of Canada boosted their price target on shares of CVS Health to $101.00 and gave the stock an “outperform” rating in a research note on Tuesday, September 18th. Bank of America boosted their price target on shares of CVS Health from $86.00 to $90.00 and gave the stock a “buy” rating in a research note on Monday, September 17th. Leerink Swann set a $80.00 price target on shares of CVS Health and gave the stock an “outperform” rating in a research note on Thursday, August 9th. Finally, Citigroup reiterated a “buy” rating and set a $81.00 price target on shares of CVS Health in a research note on Monday, July 9th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, ten have issued a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus target price of $86.31.
CVS stock opened at $74.18 on Friday. The stock has a market cap of $75.88 billion, a P/E ratio of 11.31, a P/E/G ratio of 0.99 and a beta of 1.02. CVS Health Corp has a 52 week low of $60.14 and a 52 week high of $83.88. The company has a current ratio of 2.34, a quick ratio of 1.87 and a debt-to-equity ratio of 1.73.
CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, August 8th. The pharmacy operator reported $1.69 EPS for the quarter, topping analysts’ consensus estimates of $1.61 by $0.08. The firm had revenue of $46.71 billion for the quarter, compared to the consensus estimate of $46.34 billion. CVS Health had a net margin of 1.61% and a return on equity of 18.25%. The firm’s revenue was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.33 earnings per share. On average, equities analysts predict that CVS Health Corp will post 7.05 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Investors of record on Wednesday, October 24th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.70%. The ex-dividend date is Tuesday, October 23rd. CVS Health’s dividend payout ratio is currently 33.90%.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Further Reading: Average Daily Trade Volume – What It Means In Stock Trading
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.